Area of research
Orthopedics and Sports Medicine · Oncology
Research interest
Research focused on Denosumab and Osteoporosis, with related work in Glucocorticoid, Lipidomics, Primary hyperparathyroidism. Notable publications include 'Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review', 'Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society', and 'Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study'.
Magnesium as an endocrine modulator: physiological roles, clinical evidence, and therapeutic perspectives
Transition Care for Young Persons with Rare Bone Mineral Conditions: A Consensus Recommendation from the ECTS Rare Bone Disease Action Group
Treating osteoporosis with denosumab or bisphosphonates in the long term: facts, uncertainties and assumptions. A narrative review by the clinical action group of the European Calcified Tissue Society (ECTS)
The Effects of Obesity and Weight Loss Interventions on Bone Health: A Narrative Review
Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society
Primary hyperparathyroidism: from guidelines to outpatient clinic
Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when?
Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study
Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review
Ιrisin levels in postmenopausal women with an incident hip fracture